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Introduction
Zika virus (ZIKV), a mosquito-borne flavivirus, has lately 
come to international attention owing to outbreaks on Yap 
Island, Federated States of Micronesia, in 2007 [1] and 
in French Polynesia beginning in 2013 [2], and a current 
epidemic after its recent introduction to Brazil [3]. Both 
epidemics have been attributed to the Asian genotype of 
ZIKV [2, 3], likely introduced by viremic travelers. The 
virus is maintained in a natural cycle involving non-human 
primates and various Aedes mosquito species [4]. ZIKV 
causes a self-limiting, dengue fever (DF)-like disease with 
an incubation time of up to 10 days. Signs and symptoms 
consist of rather low-grade fever, myalgia and a maculo-
papular rash, accompanied by arthralgia and headache, 
and less often edema, sore throat, and vomiting [1–4]. In 
contrast to DF, acute Zika fever (ZF) is less severe; head-
ache and malaise are less intense and haemorrhagic and 
shock complications have not been reported. Conjunctivi-
tis is often present, whereas arthralgia is less pronounced 
[1]. However, unusual rates of Guillain Barré syndrome 
(GBS) were reported in French Polynesia due to ZIKV 
infection [5]. Laboratory changes include transient leuko-
penia and in some cases thrombocytopenia. Serum aspar-
tate aminotransferase (AST) and alanine aminotransferase 
(ALT) concentrations may or may not be elevated [6]. 
Travel-associated infections from both endemic ([6, 7] as 
examples) and epidemic areas [8, 9] have been documented 
in non-endemic countries, including the recent report of a 
patient seen in Italy who became infected in Salvador de 
Bahia state, Brazil, in the current evolving outbreak.
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Whereas the clinical syndrome and laboratory diagnos-
tic procedures, including generic and real-time reverse tran-
scription polymerase chain reactions (RT-PCRs) as well as 
specific non-commercial serology tests and cross-reactions 
have been described, little attention was paid to the immu-
nology of the disease and its putative use for clinical fol-
low-up of patients. Here, we analyzed serum cytokine lev-
els of travel-associated infections and demonstrate cytokine 
concentration changes in acute and recovery (reconvales-
cent) sera. These changes suggested that strong and multi-
functional T cell responses are required for recovery from 
ZIKV infection.
Patients and methods
Sera from six patients (three males, three females) aged 
31–62 years (median 41 years) were used for this study. 
Patients had acquired ZIKV infection in Southeast Asia, 
Polynesia, or Brazil. Blood was drawn from infected patients 
at different times after disease onset (4–62 days). Sera were 
classified as either acute (taken ≤10 days after symptom 
onset) or recovery (taken >10 days after disease onset). 
ZIKV infection was diagnosed serologically, and in one case 
also molecularly by RT-PCR [8]; see Table 1 for details. 
From all sera, individual multiplex cytokine serum analyses 
(Bio-Rad Laboratories, Munich, Germany) were performed 
and 20 sera from healthy blood donors were run in parallel. 
Written informed consent was obtained from each patient.
Results
In the acute phase of ZF, significant concentration eleva-
tions were found for interleukin (IL)-1b, IL-2, IL-4, IL-6, 
IL-9, IL-10, IL-13, IL-17, as well as for interferon-γ-induced 
protein 10 (IP-10), regulated on activation, normal T cell 
expressed and secreted (RANTES), macrophage inflam-
matory protein 1 alpha (MIP-1a) and vascular endothelial 
growth factor (VEGF), when compared to normal controls. 
In the recovery phase, significant increases were demon-
strated in the levels of IL-1b, IL-6, IL-8, IL-10, IL-13, as 
well as of IP-10, RANTES, MIP-1a, MIP-1b, and VEGF, 
fibroblast growth factor (FGF), granulocyte-macrophage 
colony stimulating factor (GM-CSF), in comparison with 
healthy controls. Interferon-γ (IFN-γ) levels showed an 
increasing trend in the acute and recovery phase (non-signif-
icant), whereas tumor necrosis factor-α (TNF-α) concentra-
tions only showed a median increase during the acute phase 
(also non-significant). Many of the cytokines and factors that 
were elevated in the acute phase showed a tendency to return 
to normal levels in the later recovery phase (Figs. 1, 2). 
No significant changes, neither in the acute nor in the 
recovery phase, could be observed for IL-1ra, IL-5, IL-7, 
IL-12, monocyte chemotactic protein 1 (MCP-1), eotaxin, 
and platelet-derived growth factor-bb (PDGF-bb; data not 
shown). There were no significant changes between any of 
the cytokine levels measured in the acute versus the recov-
ery phase.
Discussion
In contrast to the clinically similar DF, acute ZIKV infec-
tions are less severe and secondary infections are not 
described owing to the fact that only one serotype of ZIKV 
exists. After an acute ZIKV infection immunity to re-infec-
tion is established for an unknown time span, based on epi-
demiological evidence from past outbreaks [1, 2]. In the 
patients studied here, elevation of chemokines was more 
pronounced than elevation of cytokines. In the recovery 
phase, cytokine levels generally decreased. A polyfunc-
tional immune activation was seen during the acute phase 
of ZF, as reflected by elevated cytokine profiles associated 
with Th1 (IL-2, and non-significantly IFN-γ), Th2 (IL-
4, IL-13), Th17 (IL-17), and also Th9 (IL-9) responses. 
Data on IL-9 functions during human viral infection is 
scarce, but studies have shown an association of elevated 
IL-9 levels and severe acute respiratory syncytial virus 
infections [10] and non-response to treatment of chronic 
hepatitis C [11], suggesting a modulator role of antiviral 
immunity. In our study, IL-2, IFN-γ and TNF-α levels 
were surprisingly lower than expected, contrasting with 
findings in other arboviral infections [12, 13]. Of note, 
Table 1  Characteristics of patients infected with Zika virus included in the study
Patient number Age Sex Serum taken after disease onset (days) Travel history Reference
1 53 Male 31 Thailand Tappe et al. [6]
2 33 Female 35 and 62 Tahiti Zammarchi et al. [8]
3 31 Male 33 Tahiti Zammarchi et al. [8]
4 45 Female 5 and 10 Malaysia Tappe et al. [7]
5 62 Male 4 and 26 Brazil Zammarchi et al. [9]
6 37 Female 5 Brazil Unpublished
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in our study RANTES is already increased in the acute 
phase, whereas IP-10 is particularly elevated in the recov-
ery phase. Effective T cell recruitment to infection sites 
and formation of effector T cells was suggested by both 
increased RANTES and IP-10 concentrations [14, 15]. 
Since CCR5 and CxCR3 are chemokine ligands receptors 
for RANTES and IP-10, respectively, immunophenotyp-
ing of peripheral blood T cells of ZIKV-infected patients 
as well as functional T cell assays should help to further 
explore the role of RANTES and IP-10 during ZF. Simi-
lar to descriptions of patients infected with dengue virus 
(DENV) [16], a related flavivirus, sera of patients with ZF 
analyzed in our study also showed increased IL-4, IL-6, 
IL-8, IL-10, and IP-10 levels. IL-10 levels were also high-
est in the later (recovery) phase of ZIKV infection, as seen 
in DF [14]. In contrast to DF, however, concentrations of 
IL-1ß, IL-2, MCP-1, and VEGF were not decreased in ZF 
patients. In DF, elevated IL-8 and IL-10 levels were shown 
to be associated with severe infection [14], a clinical state 
which has so far not been seen in ZF. No “cytokine storm 
effects”, as known from DENV infections [17] were dem-
onstrated in the ZF patients in our study. Of note, signifi-
cantly increased IFN-γ and TNF-α levels were absent in 
ZF in contrast to DF, pointing toward a Th2 bias in ZIKV 
infections. In DENV infections, thrombocytopenia corre-
lated strongly with RANTES and VEGF levels [16]. Both 
RANTES, a chemokine stored in a-granules of platelets, 
secreted upon platelet activation, and VEGF, a growth fac-
tor released by platelets, would be expected to decrease 
upon thrombocytopenia. In contrast, severe thrombocy-
topenia is rarely observed in ZF patients and RANTES 
and VEGF did not show decreased levels when compared 
with the control group. It remains to be elucidated whether 
ZIKV-induced GBS [5] might be associated with different 
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Fig. 1  Changes in cytokine levels in the acute and recovery phase 
of Zika fever. With the exception of IL-8, significant elevations of 
the serum interleukin concentrations are evident in the early, acute 
phase of Zika fever. In the recovery phase, IL-1b, IL-8, and IL-10 lev-
els were higher than in the acute phase, whereas levels of the other 
depicted cytokines were declining. Box-and-whisker plots show-
ing median, upper and lower quartile, minimum, and maximum val-
ues. *P < 0.05, **P < 0.01, ***P < 0.001, versus healthy controls 
(Kruskal–Wallis test)
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cytokine responses than changes in non-GBS ZIKV-
infected patients.
Due to the small number of ZF patients examined, this 
study and the strength of the observations are limited. 
We have analyzed cytokine levels over time in return-
ing travelers to Europe, and it is unknown whether differ-
ent human ethnic groups might show different cytokine 
responses as described for DF [18]. Recent ZF epidemics 
were only caused by the Asian genotype of ZIKV, which 
is the same genotype also seen in travel-related infections 
from outbreak areas. Thus, the cytokine data presented 
here are linked to an infection with the Asian genotype. 
As a restriction of the study, functional T cell tests (i.e., 
stimulation with ZIKV antigen followed by intracellular 
cytokine staining) have not been performed. Future studies 
will address lymphocyte and cytokine responses in more 
detail, allowing proper conclusions of Th1- and Th2-biased 
cell responses. Despite showing rather preliminary data, to 
our knowledge, this is the first study investigating immune 
parameters in acute ZF.
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Fig. 2  Changes in cytokine and growth factor levels in the acute and 
recovery phase of Zika fever. RANTES, MIP-1a, and VEGF levels 
were higher in the acute than in the recovery phase, whereas IP-10, 
MIP-1b, and GM-CSF reached higher concentrations in the recovery 
phase than during acute infection. IFN-γ levels showed a non-signifi-
cant, however, increasing trend over the course of infection, whereas 
TNF-α concentrations only displayed a non-significant median 
increase in the acute phase. Box-and-whisker plots showing median, 
upper and lower quartile, minimum, and maximum values. *P < 0.05, 
**P < 0.01, ***P < 0.001, versus healthy controls (Kruskal–Wallis 
test)
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